Reference
Nicod E, et al. Dealing with Uncertainty and Accounting for Social Value Judgments in Assessments of Orphan Drugs: Evidence from Four European Countries. Value in Health 20: 919-926, No. 7, Jul 2017. Available from: URL: http://dx.doi.org/10.1016/j.jval.2017.03.005
Rights and permissions
About this article
Cite this article
Uncertain evidence may affect HTA outcomes for orphan drugs. PharmacoEcon Outcomes News 785, 37 (2017). https://doi.org/10.1007/s40274-017-4287-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4287-y